Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

Neurology

Volumn 60, Issue 8, 2003, Pages 1374-1377

  Chetelat G ^a   Desgranges, B ^a   De la Sayette, V ^a   Viader, F ^a,c   Eustache, F ^a,b   Baron, Jean Claude ^d  

^a UNIVERSITÉ DE CAEN   (France)

^b CNRS   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ACCURACY; ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; MEDICAL ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SAMPLING; TEMPORAL CORTEX;

EID: 0037461347     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000055847.17752.E6     Document Type: Article

References (10)

1. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
2. Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
3. Kogure D, Matsuda H, Ohnishi T, et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000;41:1155-1162.
4. Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-1571.
5. Tanaka M, Fukuyama H, Yamauchi H, et al. Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. J Neuroimaging 2002;12:112-118.
6. de Santi S, de Leon M, Rusineck H, et al. Hippocampal formation, glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 2001;22:529-539.
7. Celsis P, Agniel A, Cardebat D, et al. Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance. J Neurol Neurosurg Psychiatry 1997;62:601-608.
8. Arnaiz E, Jelic V, Almkvist O, et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 2001;12:851-855.
9. Chételat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron J-C. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 2002;13:1939-1943.
10. Desgranges B, Baron J-C, Lalevée C, et al. The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationships to degree of deterioration. Brain 2002;125:1116-1124.